Current status of the molecular genetics of human prostatic adenocarcinomas
β Scribed by Dev Karan; Ming-Fong Lin; Sonny L. Johansson; Surinder K. Batra
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 447 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Molecular genetic mechanisms involved in the progression of prostate cancer are not well understood due to extensive tumor heterogeneity and lack of suitable models. New methods such as fluorescence inβsitu hybridization (FISH), comparative genomic hybridization (CGH) and microsatellite analysis have documented losses or gains on various chromosomes. Altered chromosomal regions have been associated with the activation of oncogenes and the inactivation of tumor suppressor genes or defects in mismatch repair (MMR) genes. It is suggested that increased genomic instability is associated with decreased androgenβresponsive and progressive behavior of human prostate tumors, but it remains unclear whether this genomic instability is causing the progression of cancer or is the consequence of cancer. Extended studies on hereditary prostate cancer have identified 7 prostate cancer susceptibility loci on several chromosomes, but no specific gene has been confined for a large proportion of susceptibility. In this review we summarize the ongoing molecular genetic events associated with the sporadic and hereditary prostate cancer development and progression. Β© 2002 WileyβLiss, Inc.
π SIMILAR VOLUMES
In order to investigate the genomic instability associated with prostate cancer, 36 microsatellite marker loci on chro- mosomes 1p, 3p, 5q, 8p, 8q, 9p, 11q and13q were analyzed using microdissected samples from prostate cancer and adjoining microscopically normal tissues from the same slide. DNA was
The loss o r mutational inactivation of the RBI tumor suppressor gene has been implicated in the development of a diverse group of human malignancies. However, the contribution of the RBI gene alteration t o human prostatic carcinogenesis has been poorly understood. Thus far, deletion of the promote